Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2026

According to the report, the global pneumococcal vaccines market was valued at US$ 7,847.6 Mn in 20187 and is anticipated expand at a CAGR of 3.6% from 2019 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise in health care expenditure, and surge in product approvals are projected to augment the global market from 2019 to 2026.

The report analyzes and forecasts the pneumococcal vaccines market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.

This report first introduces the background of pneumococcal vaccines, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major pneumococcal vaccines companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of pneumococcal vaccines upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of pneumococcal vaccines and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global pneumococcal vaccines market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the pneumococcal vaccines market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of pneumococcal vaccines market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Companies Mentioned in Report

The report also profiles major players in the global pneumococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Pfizer, Inc., Merck & Co., Inc., SK Chemicals, Serum Institute of India Pvt. Ltd., Chengdu Institute of Biological Products Co., Ltd., GlaxoSmithKline plc, Sanofi, and Walvax Biotechnology Co., Ltd.

The global pneumococcal vaccines market has been segmented as below:

  • Global Pneumococcal Vaccines Market, by Product Type
    • Synflorix
      • Pediatric
      • Adult
    • Prevenar-13
      • Pediatric
      • Adult
    • PCV 13 (pipeline)
      • Pediatric
      • Adult
    • V114 (Merck)
      • Pediatric
      • Adult
    • PCV-20 (Pfizer)
      • Pediatric
      • Adult
    • PCV-10 (SII)
      • Pediatric
      • Adult
    • PPSV- 23
      • Pediatric
      • Adult
  • Global Pneumococcal Vaccines Market, by Distribution Channel
    • Wholesalers (pharmacy channel)
    • Specialized Companies
    • Public Authorities
    • Others
  • Global Pneumococcal Vaccines Market, by Sector
    • Public
    • Private
  • Global Pneumococcal Vaccines Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Italy
      • France
      • Spain
      • Belgium
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Rest of the World
      • Middle East
      • Africa

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global pneumococcal vaccines capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Market value USD Million and volume Units Million data for each segment and sub-segment
  • Focuses on the key pneumococcal vaccines manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Pneumococcal Vaccines Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
3.2. Global Pneumococcal Vaccines Market: Market Snapshot, 2018

4. Market Overview
4.1. Overview
4.2. Global Pneumococcal Vaccines Market Size (US$ Mn) Forecast, 2018–2026
4.3. Global Pneumococcal Vaccines Market Outlook
4.4. Approved & Pipeline Products Snapshot

5. Market Dynamics
5.1. Drivers
5.1.1. Government participation in design & implementation of comprehensive vaccination programs
5.1.2. Increase in investments by public & private players in R&D of conjugate pneumococcal vaccines
5.2. Restraints
5.2.1. Longer timeline and high cost associated with development of pneumococcal vaccines
5.3. Opportunities
5.3.1. Development of multivalent conjugated vaccines with different serotypes
5.4. Trends
5.4.1. Public-Private Partnerships

6. Global Pneumococcal Vaccines Market Analysis, by Product Type
6.1. Introduction
6.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Product Type
6.3. Pneumococcal Vaccines Market Analysis, by Product Type
6.3.1. Synflorix
6.3.1.1. Pediatric
6.3.1.2. Adult
6.3.2. Prevenar-13
6.3.2.1. Pediatric
6.3.2.2. Adult
6.3.3. PCV 13 (pipeline)
6.3.3.1. Pediatric
6.3.3.2. Adult
6.3.4. V114 (Merck)
6.3.4.1. Pediatric
6.3.4.2. Adult
6.3.5. PCV-20 (Pfizer)
6.3.5.1. Pediatric
6.3.5.2. Adult
6.3.6. PCV-10 (SII)
6.3.6.1. Pediatric
6.3.6.2. Adult
6.3.7. PPSV- 23
6.3.7.1. Pediatric
6.3.7.2. Adult

7. Global Pneumococcal Vaccines Market Analysis, by Distribution Channel
7.1. Introduction
7.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
7.3. Pneumococcal Vaccines Market Analysis, by Distribution Channel
7.3.1. Wholesalers
7.3.2. Specialized Companies
7.3.3. Public Authorities
7.3.4. Others

8. Global Pneumococcal Vaccines Market Analysis, by Sector
8.1. Introduction
8.2. Global Pneumococcal Vaccines Market Value Share Analysis, by Sector
8.3. Pneumococcal Vaccines Market Analysis, by Sector
8.3.1. Public
8.3.2. Private

9. U.S. Pneumococcal Vaccines Market Analysis
9.1. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
9.2. U.S. Pneumococcal Vaccines Market Forecast, by Product Type
9.2.1. Prevanar-13
9.2.2. V114
9.2.3. PCV-20
9.2.4. Pneumovax-23
9.3. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
9.4. U.S. Pneumococcal Vaccines Market Forecast, by Distribution Channel
9.4.1. Wholesalers
9.4.2. Specialized Companies
9.4.3. Public Authorities
9.4.4. Others
9.5. U.S. Pneumococcal Vaccines Market Value Share Analysis, by Sector
9.6. U.S. Pneumococcal Vaccines Market Forecast, by Sector
9.6.1. Private
9.6.2. Public
10. Canada Pneumococcal Vaccines Market Analysis

10.1. Canada Pneumococcal Vaccines Market Value Share Analysis, by Product Type
10.2. Canada Pneumococcal Vaccines Market Forecast, by Product Type
10.2.1. Prevenar-13
10.2.2. Synflorix
10.2.3. V-114
10.2.4. Pneumo - 23
10.2.5. Pnuemovax-23
10.3. Canada Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
10.4. Canada Pneumococcal Vaccines Market Forecast, by Distribution Channel
10.4.1. Wholesalers
10.4.2. Specialized Companies
10.4.3. Public Authorities
10.4.4. Others
10.5. Canada Pneumococcal Vaccines Market Value Share Analysis, by Sector
10.6. Canada Pneumococcal Vaccines Market Forecast, by Sector
10.6.1. Private
10.6.2. Public

11. Germany Pneumococcal Vaccines Market Analysis
11.1. Germany Pneumococcal Vaccines Market Value Share Analysis, by Product Type
11.2. Germany Pneumococcal Vaccines Market Forecast, by Product Type
11.2.1. Prevenar-13
11.2.2. Synflorix
11.2.3. V-114
11.2.4. PCV-20
11.2.5. Pnuemovax-23
11.3. Germany Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
11.4. Germany Pneumococcal Vaccines Market Forecast, by Distribution Channel
11.4.1. Wholesalers
11.4.2. Specialized Companies
11.4.3. Public Authorities
11.4.4. Others
11.5. Germany Pneumococcal Vaccines Market Value Share Analysis, by Sector
11.6. Germany Pneumococcal Vaccines Market Forecast, by Sector
11.6.1. Private
11.6.2. Public

12. U.K. Pneumococcal Vaccines Market Analysis
12.1. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Product Type
12.2. U.K. Pneumococcal Vaccines Market Forecast, by Product Type
12.2.1. Prevenar-13
12.2.2. Synflorix
12.2.3. V-114
12.2.4. PCV-20
12.2.5. Pnuemovax-23
12.3. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
12.4. U.K. Pneumococcal Vaccines Market Forecast, by Distribution Channel
12.4.1. Wholesalers
12.4.2. Specialized Companies
12.4.3. Public Authorities
12.4.4. Others
12.5. U.K. Pneumococcal Vaccines Market Value Share Analysis, by Sector
12.6. U.K. Pneumococcal Vaccines Market Forecast, by Sector
12.6.1. Private
12.6.2. Public

13. France Pneumococcal Vaccines Market Analysis
13.1. France Pneumococcal Vaccines Market Value Share Analysis, by Product Type
13.2. France Pneumococcal Vaccines Market Forecast, by Product Type
13.2.1. Prevenar-13
13.2.2. Synflorix
13.2.3. V-114
13.2.4. PCV-20
13.2.5. Pnuemovax-23
13.3. France Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
13.4. France Pneumococcal Vaccines Market Forecast, by Distribution Channel
13.4.1. Wholesalers
13.4.2. Specialized Companies
13.4.3. Public Authorities
13.4.4. Others
13.5. France Pneumococcal Vaccines Market Value Share Analysis, by Sector
13.6. France Pneumococcal Vaccines Market Forecast, by Sector
13.6.1. Private
13.6.2. Public

14. Italy Pneumococcal Vaccines Market Analysis
14.1. Italy Pneumococcal Vaccines Market Value Share Analysis, by Product Type
14.2. Italy Pneumococcal Vaccines Market Forecast, by Product Type
14.2.1. Prevenar-13
14.2.2. Synflorix
14.2.3. V-114
14.2.4. PCV-20
14.2.5. Pnuemovax-23
14.3. Italy Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
14.4. Italy Pneumococcal Vaccines Market Forecast, by Distribution Channel
14.4.1. Wholesalers
14.4.2. Specialized Companies
14.4.3. Public Authorities
14.4.4. Others
14.5. Italy Pneumococcal Vaccines Market Value Share Analysis, by Sector
14.6. Italy Pneumococcal Vaccines Market Forecast, by Sector
14.6.1. Private
14.6.2. Public

15. Spain Pneumococcal Vaccines Market Analysis
15.1. Spain Pneumococcal Vaccines Market Value Share Analysis, by Product Type
15.2. Spain Pneumococcal Vaccines Market Forecast, by Product Type
15.2.1. Prevenar-13
15.2.2. Synflorix
15.2.3. V-114
15.2.4. PCV-20
15.2.5. Pnuemovax-23
15.3. Spain Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
15.4. Spain Pneumococcal Vaccines Market Forecast, by Distribution Channel
15.4.1. Wholesalers
15.4.2. Specialized Companies
15.4.3. Public Authorities
15.4.4. Others
15.5. Spain Pneumococcal Vaccines Market Value Share Analysis, by Sector
15.6. Spain Pneumococcal Vaccines Market Forecast, by Sector
15.6.1. Private
15.6.2. Public

16. Belgium Pneumococcal Vaccines Market Analysis
16.1. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Product Type
16.2. Belgium Pneumococcal Vaccines Market Forecast, by Product Type
16.2.1. Prevenar-13
16.2.2. Synflorix
16.2.3. V-114
16.2.4. PCV-20
16.2.5. Pnuemovax-23
16.3. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
16.4. Belgium Pneumococcal Vaccines Market Forecast, by Distribution Channel
16.4.1. Wholesalers
16.4.2. Specialized Companies
16.4.3. Public Authorities
16.4.4. Others
16.5. Belgium Pneumococcal Vaccines Market Value Share Analysis, by Sector
16.6. Belgium Pneumococcal Vaccines Market Forecast, by Sector
16.6.1. Private
16.6.2. Public

17. India Pneumococcal Vaccines Market Analysis
17.1. India Pneumococcal Vaccines Market Value Share Analysis, by Product Type
17.2. India Pneumococcal Vaccines Market Forecast, by Product Type
17.2.1. Prevenar-13
17.2.2. Synflorix
17.2.3. SIIL PCV-10
17.2.4. PCV-20
17.2.5. Pnuemovax-23
17.3. India Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
17.4. India Pneumococcal Vaccines Market Forecast, by Distribution Channel
17.4.1. Wholesalers
17.4.2. Specialized Companies
17.4.3. Public Authorities
17.4.4. Others
17.5. India Pneumococcal Vaccines Market Value Share Analysis, by Sector
17.6. India Pneumococcal Vaccines Market Forecast, by Sector
17.6.1. Private
17.6.2. Public
18. China Pneumococcal Vaccines Market Analysis
18.1. China Pneumococcal Vaccines Market Value Share Analysis, by Product Type
18.2. China Pneumococcal Vaccines Market Forecast, by Product Type
18.2.1. Prevenar-13
18.2.2. PCV 13 (pipeline)
18.2.3. PPSV 23
18.3. China Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
18.4. China Pneumococcal Vaccines Market Forecast, by Distribution Channel
18.4.1. Wholesalers
18.4.2. Specialized Companies
18.4.3. Public Authorities
18.4.4. Others
18.5. China Pneumococcal Vaccines Market Value Share Analysis, by Sector
18.6. China Pneumococcal Vaccines Market Forecast, by Sector
18.6.1. Private
18.6.2. Public

19. Japan Pneumococcal Vaccines Market Analysis
19.1. Japan Pneumococcal Vaccines Market Value Share Analysis, by Product Type
19.2. Japan Pneumococcal Vaccines Market Forecast, by Product Type
19.2.1. Prevenar-13
19.2.2. Synflorix
19.2.3. PPSV 23
19.3. Japan Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
19.4. Japan Pneumococcal Vaccines Market Forecast, by Distribution Channel
19.4.1. Wholesalers
19.4.2. Specialized Companies
19.4.3. Public Authorities
19.4.4. Others
19.5. Japan Pneumococcal Vaccines Market Value Share Analysis, by Sector
19.6. Japan Pneumococcal Vaccines Market Forecast, by Sector
19.6.1. Private
19.6.2. Public

20. Australia Pneumococcal Vaccines Market Analysis
20.1. Australia Pneumococcal Vaccines Market Value Share Analysis, by Product Type
20.2. Australia Pneumococcal Vaccines Market Forecast, by Product Type
20.2.1. Prevenar-13
20.2.2. Synflorix
20.2.3. V114
20.2.4. Pnuemovax-23
20.3. Australia Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
20.4. Australia Pneumococcal Vaccines Market Forecast, by Distribution Channel
20.4.1. Wholesalers
20.4.2. Specialized Companies
20.4.3. Public Authorities
20.4.4. Others
20.5. Australia Pneumococcal Vaccines Market Value Share Analysis, by Sector
20.6. Australia Pneumococcal Vaccines Market Forecast, by Sector
20.6.1. Private
20.6.2. Public

21. New Zealand Pneumococcal Vaccines Market Analysis
21.1. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Product Type
21.2. New Zealand Pneumococcal Vaccines Market Forecast, by Product Type
21.2.1. Prevenar-13
21.2.2. Synflorix
21.2.3. Pnuemovax-23
21.3. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
21.4. New Zealand Pneumococcal Vaccines Market Forecast, by Distribution Channel
21.4.1. Wholesalers
21.4.2. Specialized Companies
21.4.3. Public Authorities
21.4.4. Others
21.5. New Zealand Pneumococcal Vaccines Market Value Share Analysis, by Sector
21.6. New Zealand Pneumococcal Vaccines Market Forecast, by Sector
21.6.1. Private
21.6.2. Public

22. Brazil Pneumococcal Vaccines Market Analysis
22.1. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Product Type
22.2. Brazil Pneumococcal Vaccines Market Forecast, by Product Type
22.2.1. Prevenar-13
22.2.2. Synflorix
22.2.3. Pnuemovax-23
22.3. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
22.4. Brazil Pneumococcal Vaccines Market Forecast, by Distribution Channel
22.4.1. Wholesalers
22.4.2. Specialized Companies
22.4.3. Public Authorities
22.4.4. Others
22.5. Brazil Pneumococcal Vaccines Market Value Share Analysis, by Sector
22.6. Brazil Pneumococcal Vaccines Market Forecast, by Sector
22.6.1. Private
22.6.2. Public

23. Mexico Pneumococcal Vaccines Market Analysis
23.1. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Product Type
23.2. Mexico Pneumococcal Vaccines Market Forecast, by Product Type
23.2.1. Prevenar-13
23.2.2. Synflorix
23.2.3. Pnuemovax-23
23.3. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
23.4. Mexico Pneumococcal Vaccines Market Forecast, by Distribution Channel
23.4.1. Wholesalers
23.4.2. Specialized Companies
23.4.3. Public Authorities
23.4.4. Others
23.5. Mexico Pneumococcal Vaccines Market Value Share Analysis, by Sector
23.6. Mexico Pneumococcal Vaccines Market Forecast, by Sector
23.6.1. Private
23.6.2. Public

24. Rest of the World Pneumococcal Vaccines Market Analysis
24.1. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Product Type
24.2. Rest of the World Pneumococcal Vaccines Market Forecast, by Product Type
24.2.1. Prevenar-13
24.2.2. Synflorix
24.2.3. V-114
24.2.4. PCV-20
24.2.5. PCV-10 (SII)
24.2.6. Pnuemovax-23
24.3. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Distribution Channel
24.4. Rest of the World Pneumococcal Vaccines Market Forecast, by Distribution Channel
24.4.1. Wholesalers
24.4.2. Specialized Companies
24.4.3. Public Authorities
24.4.4. Others
24.5. Rest of the World Pneumococcal Vaccines Market Value Share Analysis, by Sector
24.6. Rest of the World Pneumococcal Vaccines Market Forecast, by Sector
24.6.1. Private
24.6.2. Public
24.7. Rest of the World Pneumococcal Vaccines Market Forecast, by Region

25. Competition Landscape
25.1. Global Pneumococcal Vaccines Market Share Analysis, by Company (2017)
25.2. Company Profiles
25.2.1. Pfizer, Inc.
25.2.2. Merck & Co., Inc.
25.2.3. SK Chemicals
25.2.4. Serum Institute of India Pvt. Ltd.
25.2.5. Chengdu Institute of Biological Products Co., Ltd.
25.2.6. GlaxoSmithKline plc
25.2.7. Sanofi
25.2.8. Walvax Biotechnology Co., Ltd.

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert